Profile
Kenneth F.
Boehm held several positions in human resources throughout his career.
He started as the Vice President-Human Resources at Synopsys, Inc. from 2010 to 2013.
He then worked as the Senior Vice President-Human Resources at Pharmacyclics LLC.
In 2013, he became the Vice President-Human Resources at Polycom, Inc. until 2014.
From 2014 to 2015, he served as the Senior Vice President-Human Resources at E2open LLC.
Mr. Boehm also worked as the Vice President-Human Resources at Gilead Sciences, Inc. from 2009 to 2020.
Prior to that, he was the Vice President-Human Resource at PalmSource, Inc. from 2002 to 2005 and the Vice President-Human Resources at CV Therapeutics, Inc. from 2005 to 2009.
He later became the Vice President-Human Resources at Aimmune Therapeutics, Inc. from 2015 to 2018.
Currently, he is the Senior Vice President-Human Resources at CymaBay Therapeutics, Inc. from 2019 to 2024.
Mr. Boehm obtained his undergraduate degree from the University of California, Los Angeles.
He also holds a doctorate degree from Golden Gate University and an MBA from Pepperdine University.
Former positions of Kenneth F. Boehm
| Companies | Position | End |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Human Resources Officer | 21/03/2024 |
| GILEAD SCIENCES, INC. | Human Resources Officer | 30/04/2020 |
| AIMMUNE THERAPEUTICS, INC. | Human Resources Officer | 31/03/2018 |
| E2OPEN INC | Human Resources Officer | 31/07/2015 |
| POLYCOM INC | Human Resources Officer | 30/04/2014 |
Training of Kenneth F. Boehm
| University of California, Los Angeles | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
| Golden Gate University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SYNOPSYS INC. | Technology Services |
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
E2open LLC
 E2open LLC Packaged SoftwareTechnology Services E2open LLC provides solutions for supply chain management. It serves the pharmaceutical, consumer goods, industrial manufacturing and automotive sectors. The firm’s solutions include channel data management, inventory visibility, sourcing and procurement. The company was founded by John B. Mumford in July 2000 and is headquartered in Austin, TX. | Technology Services |
Polycom, Inc.
 Polycom, Inc. Electronics/AppliancesConsumer Durables Polycom, Inc. develops video, voice and content collaboration and communication technology. It offers consult, deployment, customer support, optimization, managed and cloud services. The firm serves healthcare, education, entertainment, government and finance industries. It offers solutions through Polycom RealPresence platform. The company was founded by Brian L. Hinman and Jeffrey Rodman in December 1990 and is headquartered in San Jose, CA. | Consumer Durables |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
PalmSource, Inc.
 PalmSource, Inc. Packaged SoftwareTechnology Services Palmsource, Inc. develops and licenses platform software. It has enhanced its platform with applications such as personal information management software, web browsers and e-mail. A wide range of smart mobile devices incorporate its solutions, including personal digital assistants. | Technology Services |
- Stock Market
- Insiders
- Kenneth F. Boehm
